Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Journal
Age
Showing 1 to 12 of 9375 entries
Sorted by: Best Match Show Resources per page
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

Clinical pharmacokinetics

Staatz CE, Tett SE.
PMID: 17201457
Clin Pharmacokinet. 2007;46(1):13-58. doi: 10.2165/00003088-200746010-00002.

This review aims to provide an extensive overview of the literature on the clinical pharmacokinetics of mycophenolate in solid organ transplantation and a briefer summary of current pharmacodynamic information. Strategies are suggested for further optimisation of mycophenolate therapy and...

Cite
Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet. 2007;46(1):13-58doi: 10.2165/00003088-200746010-00002.
Staatz, C. E., & Tett, S. E. (2007). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clinical pharmacokinetics, 46(1), 13-58. https://doi.org/10.2165/00003088-200746010-00002
Staatz, Christine E, and Tett, Susan E. "Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients." Clinical pharmacokinetics vol. 46,1 (2007): 13-58. doi: https://doi.org/10.2165/00003088-200746010-00002
Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet. 2007;46(1):13-58. doi: 10.2165/00003088-200746010-00002. PMID: 17201457.
Copy Download .nbib Format: NLM
Ontogeny of P2-purinoceptors in the longitudinal muscle and muscularis mucosae of the rat isolated duodenum.

British journal of pharmacology

Brownhill VR, Hourani SM, Kitchen I.
PMID: 9313929
Br J Pharmacol. 1997 Sep;122(2):225-32. doi: 10.1038/sj.bjp.0701375.
Free PMC Article

1. The ontogeny of P2-purinoceptors in the longitudinal muscle and the muscularis mucosae of the rat isolated duodenum was investigated by use of functional assays in tissues from neonatal animals. The degradation of purinoceptor agonists by the rat duodenum...

Cite
Brownhill VR, Hourani SM, Kitchen I. Ontogeny of P2-purinoceptors in the longitudinal muscle and muscularis mucosae of the rat isolated duodenum. Br J Pharmacol. 1997;122(2):225-32doi: 10.1038/sj.bjp.0701375.
Brownhill, V. R., Hourani, S. M., & Kitchen, I. (1997). Ontogeny of P2-purinoceptors in the longitudinal muscle and muscularis mucosae of the rat isolated duodenum. British journal of pharmacology, 122(2), 225-32. https://doi.org/10.1038/sj.bjp.0701375
Brownhill, V R, et al. "Ontogeny of P2-purinoceptors in the longitudinal muscle and muscularis mucosae of the rat isolated duodenum." British journal of pharmacology vol. 122,2 (1997): 225-32. doi: https://doi.org/10.1038/sj.bjp.0701375
Brownhill VR, Hourani SM, Kitchen I. Ontogeny of P2-purinoceptors in the longitudinal muscle and muscularis mucosae of the rat isolated duodenum. Br J Pharmacol. 1997 Sep;122(2):225-32. doi: 10.1038/sj.bjp.0701375. PMID: 9313929; PMCID: PMC1564932.
Copy Download .nbib Format: NLM
In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells.

Clinica chimica acta; international journal of clinical chemistry

Raab M, Daxecker H, Karimi A, Markovic S, Cichna M, Markl P, Müller MM.
PMID: 11485760
Clin Chim Acta. 2001 Aug 01;310(1):89-98. doi: 10.1016/s0009-8981(01)00527-7.

The immunosuppressive drug mycophenolate mofetil (MMF) and its active metabolite mycophenolic acid (MPA) selectively inhibit inosine 5'-monophosphate dehydrogenase (IMPDH), and therefore interfere with cellular guanine nucleotide biosynthesis. IMPDH is additionally involved in the synthesis of membrane glycoproteins, some of...

Cite
Raab M, Daxecker H, Karimi A, et al. In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells. Clin Chim Acta. 2001;310(1):89-98doi: 10.1016/s0009-8981(01)00527-7.
Raab, M., Daxecker, H., Karimi, A., Markovic, S., Cichna, M., Markl, P., & Müller, M. M. (2001). In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells. Clinica chimica acta; international journal of clinical chemistry, 310(1), 89-98. https://doi.org/10.1016/s0009-8981(01)00527-7
Raab, M, et al. "In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells." Clinica chimica acta; international journal of clinical chemistry vol. 310,1 (2001): 89-98. doi: https://doi.org/10.1016/s0009-8981(01)00527-7
Raab M, Daxecker H, Karimi A, Markovic S, Cichna M, Markl P, Müller MM. In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cells. Clin Chim Acta. 2001 Aug 01;310(1):89-98. doi: 10.1016/s0009-8981(01)00527-7. PMID: 11485760.
Copy Download .nbib Format: NLM
Interaction of purine nucleotides with inert paramagnetic Cr(III) probes evaluated by NMR relaxation effects. Molecular mechanics calculations on Cr(III) and Co(III) polyphosphate complexes.

Journal of biomolecular structure & dynamics

Cini R, Giorgi G, Laschi F, Rossi C, Marzilli LG.
PMID: 2310520
J Biomol Struct Dyn. 1990 Feb;7(4):859-78. doi: 10.1080/07391102.1990.10508529.

The 1H NMR relaxation effects produced by paramagnetic Cr(III) complexes on nucleoside 5'-mono- and -triphosphates in D2O solution at pH' = 3 were measured. The paramagnetic probes were [Cr(III)(H2O)6]3+, [Cr(III)(H2O)3(HATP)], [Cr(III)(H2O)3(HCTP)] and [Cr(III)(H2O)3(UTP)-, while the matrix nucleotides (0.1 M)...

Cite
Cini R, Giorgi G, Laschi F, et al. Interaction of purine nucleotides with inert paramagnetic Cr(III) probes evaluated by NMR relaxation effects. Molecular mechanics calculations on Cr(III) and Co(III) polyphosphate complexes. J Biomol Struct Dyn. 1990;7(4):859-78doi: 10.1080/07391102.1990.10508529.
Cini, R., Giorgi, G., Laschi, F., Rossi, C., & Marzilli, L. G. (1990). Interaction of purine nucleotides with inert paramagnetic Cr(III) probes evaluated by NMR relaxation effects. Molecular mechanics calculations on Cr(III) and Co(III) polyphosphate complexes. Journal of biomolecular structure & dynamics, 7(4), 859-78. https://doi.org/10.1080/07391102.1990.10508529
Cini, R, et al. "Interaction of purine nucleotides with inert paramagnetic Cr(III) probes evaluated by NMR relaxation effects. Molecular mechanics calculations on Cr(III) and Co(III) polyphosphate complexes." Journal of biomolecular structure & dynamics vol. 7,4 (1990): 859-78. doi: https://doi.org/10.1080/07391102.1990.10508529
Cini R, Giorgi G, Laschi F, Rossi C, Marzilli LG. Interaction of purine nucleotides with inert paramagnetic Cr(III) probes evaluated by NMR relaxation effects. Molecular mechanics calculations on Cr(III) and Co(III) polyphosphate complexes. J Biomol Struct Dyn. 1990 Feb;7(4):859-78. doi: 10.1080/07391102.1990.10508529. PMID: 2310520.
Copy Download .nbib Format: NLM
Enzymes involved in purine metabolism--a review of histochemical localization and functional implications.

Histology and histopathology

Moriwaki Y, Yamamoto T, Higashino K.
PMID: 10506947
Histol Histopathol. 1999 Oct;14(4):1321-40. doi: 10.14670/HH-14.1321.

Many enzymes are involved in the biosynthesis, interconversion, and degradation of purine compounds. The exact function of these enzymes is still unknown, but they seem to play important roles other than in purine metabolism. To elucidate their functional roles,...

Cite
Moriwaki Y, Yamamoto T, Higashino K. Enzymes involved in purine metabolism--a review of histochemical localization and functional implications. Histol Histopathol. 1999;14(4):1321-40doi: 10.14670/HH-14.1321.
Moriwaki, Y., Yamamoto, T., & Higashino, K. (1999). Enzymes involved in purine metabolism--a review of histochemical localization and functional implications. Histology and histopathology, 14(4), 1321-40. https://doi.org/10.14670/HH-14.1321
Moriwaki, Y, et al. "Enzymes involved in purine metabolism--a review of histochemical localization and functional implications." Histology and histopathology vol. 14,4 (1999): 1321-40. doi: https://doi.org/10.14670/HH-14.1321
Moriwaki Y, Yamamoto T, Higashino K. Enzymes involved in purine metabolism--a review of histochemical localization and functional implications. Histol Histopathol. 1999 Oct;14(4):1321-40. doi: 10.14670/HH-14.1321. PMID: 10506947.
Copy Download .nbib Format: NLM
Tricarboxylic acid cycle intermediate pool size: functional importance for oxidative metabolism in exercising human skeletal muscle.

Sports medicine (Auckland, N.Z.)

Bowtell JL, Marwood S, Bruce M, Constantin-Teodosiu D, Greenhaff PL.
PMID: 18027994
Sports Med. 2007;37(12):1071-88. doi: 10.2165/00007256-200737120-00005.

The tricarboxylic acid (TCA) cycle is the major final common pathway for oxidation of carbohydrates, lipids and some amino acids, which produces reducing equivalents in the form of nicotinamide adenine dinucleotide and flavin adenine dinucleotide that result in production...

Cite
Bowtell JL, Marwood S, Bruce M, et al. Tricarboxylic acid cycle intermediate pool size: functional importance for oxidative metabolism in exercising human skeletal muscle. Sports Med. 2007;37(12):1071-88doi: 10.2165/00007256-200737120-00005.
Bowtell, J. L., Marwood, S., Bruce, M., Constantin-Teodosiu, D., & Greenhaff, P. L. (2007). Tricarboxylic acid cycle intermediate pool size: functional importance for oxidative metabolism in exercising human skeletal muscle. Sports medicine (Auckland, N.Z.), 37(12), 1071-88. https://doi.org/10.2165/00007256-200737120-00005
Bowtell, Joanna L, et al. "Tricarboxylic acid cycle intermediate pool size: functional importance for oxidative metabolism in exercising human skeletal muscle." Sports medicine (Auckland, N.Z.) vol. 37,12 (2007): 1071-88. doi: https://doi.org/10.2165/00007256-200737120-00005
Bowtell JL, Marwood S, Bruce M, Constantin-Teodosiu D, Greenhaff PL. Tricarboxylic acid cycle intermediate pool size: functional importance for oxidative metabolism in exercising human skeletal muscle. Sports Med. 2007;37(12):1071-88. doi: 10.2165/00007256-200737120-00005. PMID: 18027994.
Copy Download .nbib Format: NLM
Current and experimental treatments of Parkinson disease: A guide for neuroscientists.

Journal of neurochemistry

Oertel W, Schulz JB.
PMID: 27577098
J Neurochem. 2016 Oct;139:325-337. doi: 10.1111/jnc.13750. Epub 2016 Aug 30.

Over a period of more than 50 years, the symptomatic treatment of the motor symptoms of Parkinson disease (PD) has been optimized using pharmacotherapy, deep brain stimulation, and physiotherapy. The arsenal of pharmacotherapies includes L-Dopa, several dopamine agonists, inhibitors...

Cite
Oertel W, Schulz JB. Current and experimental treatments of Parkinson disease: A guide for neuroscientists. J Neurochem. 2016;139:325-337doi: 10.1111/jnc.13750.
Oertel, W., & Schulz, J. B. (2016). Current and experimental treatments of Parkinson disease: A guide for neuroscientists. Journal of neurochemistry, 139325-337. https://doi.org/10.1111/jnc.13750
Oertel, Wolfgang, and Schulz, Jörg B. "Current and experimental treatments of Parkinson disease: A guide for neuroscientists." Journal of neurochemistry vol. 139 (2016): 325-337. doi: https://doi.org/10.1111/jnc.13750
Oertel W, Schulz JB. Current and experimental treatments of Parkinson disease: A guide for neuroscientists. J Neurochem. 2016 Oct;139:325-337. doi: 10.1111/jnc.13750. Epub 2016 Aug 30. PMID: 27577098.
Copy Download .nbib Format: NLM
Purine in bronchoalveolar lavage fluid as a marker of ventilation-induced lung injury.

Critical care medicine

Verbrugge SJ, de Jong JW, Keijzer E, Vazquez de Anda G, Lachmann B.
PMID: 10321669
Crit Care Med. 1999 Apr;27(4):779-83. doi: 10.1097/00003246-199904000-00035.

OBJECTIVE: To investigate in a rat model of ventilation-induced lung injury whether metabolic changes in the lung are reflected by an increased purine concentration (adenosine, inosine, hypoxanthine, xanthine, and urate; an index of adenosine-triphosphate breakdown) of the bronchoalveolar lavage...

Cite
Verbrugge SJ, de Jong JW, Keijzer E, et al. Purine in bronchoalveolar lavage fluid as a marker of ventilation-induced lung injury. Crit Care Med. 1999;27(4):779-83doi: 10.1097/00003246-199904000-00035.
Verbrugge, S. J., de Jong, J. W., Keijzer, E., Vazquez de Anda, G., & Lachmann, B. (1999). Purine in bronchoalveolar lavage fluid as a marker of ventilation-induced lung injury. Critical care medicine, 27(4), 779-83. https://doi.org/10.1097/00003246-199904000-00035
Verbrugge, S J, et al. "Purine in bronchoalveolar lavage fluid as a marker of ventilation-induced lung injury." Critical care medicine vol. 27,4 (1999): 779-83. doi: https://doi.org/10.1097/00003246-199904000-00035
Verbrugge SJ, de Jong JW, Keijzer E, Vazquez de Anda G, Lachmann B. Purine in bronchoalveolar lavage fluid as a marker of ventilation-induced lung injury. Crit Care Med. 1999 Apr;27(4):779-83. doi: 10.1097/00003246-199904000-00035. PMID: 10321669.
Copy Download .nbib Format: NLM
First Report of Soybean dwarf virus (Genus Luteovirus) Infecting Faba Bean and Clover in Germany.

Plant disease

Abraham AD, Menzel W, Vetten HJ, Saucke H.
PMID: 30780466
Plant Dis. 2007 Aug;91(8):1059. doi: 10.1094/PDIS-91-8-1059B.

In 2003, leaf samples from faba bean plants (Vicia faba L.) showing slight growth reductions and yellowing symptoms were collected in a field near Hebenshausen, Hesse, Germany. Some of these samples did not react in triple-antibody sandwich enzyme-linked immunosorbent...

Cite
Abraham AD, Menzel W, Vetten HJ, et al. First Report of Soybean dwarf virus (Genus Luteovirus) Infecting Faba Bean and Clover in Germany. Plant Dis. 2007;91(8):1059doi: 10.1094/PDIS-91-8-1059B.
Abraham, A. D., Menzel, W., Vetten, H. J., & Saucke, H. (2007). First Report of Soybean dwarf virus (Genus Luteovirus) Infecting Faba Bean and Clover in Germany. Plant disease, 91(8), 1059. https://doi.org/10.1094/PDIS-91-8-1059B
Abraham, A D, et al. "First Report of Soybean dwarf virus (Genus Luteovirus) Infecting Faba Bean and Clover in Germany." Plant disease vol. 91,8 (2007): 1059. doi: https://doi.org/10.1094/PDIS-91-8-1059B
Abraham AD, Menzel W, Vetten HJ, Saucke H. First Report of Soybean dwarf virus (Genus Luteovirus) Infecting Faba Bean and Clover in Germany. Plant Dis. 2007 Aug;91(8):1059. doi: 10.1094/PDIS-91-8-1059B. PMID: 30780466.
Copy Download .nbib Format: NLM
A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.

Transplantation

[No authors listed]
PMID: 8623181
Transplantation. 1996 Apr 15;61(7):1029-37.

Mycopehenolate mofetil (MMF) is a powerful immunosuppressant that inhibits the proliferation of T and B lymphocytes by blocking the enzyme inosine monophosphate dehydrogenase. MMF has been shown to prevent acute graft rejection in animal experiments and may have an...

Cite
A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation. 1996;61(7):1029-37
(1996). A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation, 61(7), 1029-37.
"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group." Transplantation vol. 61,7 (1996): 1029-37.
A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation. 1996 Apr 15;61(7):1029-37. PMID: 8623181.
Copy Download .nbib Format: NLM
Mizoribine for the treatment of lupus nephritis in children and adolescents.

Clinical nephrology

Tanaka H, Tsugawa K, Tsuruga K, Suzuki K, Nakahata T, Ito E, Waga S.
PMID: 15630899
Clin Nephrol. 2004 Dec;62(6):412-7. doi: 10.5414/cnp62412.

AIM: The optimal treatment for lupus nephritis in the pubertal age group is still unclear. We therefore retrospectively evaluated the efficacy and safety of mizoribine (MZR), a novel selective inhibitor of inosine monophosphatase dehydrogenase, developed in Japan for the...

Cite
Tanaka H, Tsugawa K, Tsuruga K, et al. Mizoribine for the treatment of lupus nephritis in children and adolescents. Clin Nephrol. 2004;62(6):412-7doi: 10.5414/cnp62412.
Tanaka, H., Tsugawa, K., Tsuruga, K., Suzuki, K., Nakahata, T., Ito, E., & Waga, S. (2004). Mizoribine for the treatment of lupus nephritis in children and adolescents. Clinical nephrology, 62(6), 412-7. https://doi.org/10.5414/cnp62412
Tanaka, H, et al. "Mizoribine for the treatment of lupus nephritis in children and adolescents." Clinical nephrology vol. 62,6 (2004): 412-7. doi: https://doi.org/10.5414/cnp62412
Tanaka H, Tsugawa K, Tsuruga K, Suzuki K, Nakahata T, Ito E, Waga S. Mizoribine for the treatment of lupus nephritis in children and adolescents. Clin Nephrol. 2004 Dec;62(6):412-7. doi: 10.5414/cnp62412. PMID: 15630899.
Copy Download .nbib Format: NLM
Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition.

Journal of immunological methods

Tarhoni I, Wakefield CJ, Kollipara R, Fidler MJ, Batus M, Bonomi P, Borgia JA.
PMID: 33434603
J Immunol Methods. 2021 Mar;490:112956. doi: 10.1016/j.jim.2021.112956. Epub 2021 Jan 09.

BACKGROUND: Durable tumor regressions are observed in a subset of advanced-stage non-small cell lung cancer (NSCLC) patients receiving PD-1/-L1 targeted immune checkpoint inhibitors (or 'immunotherapy') alone or in combination with chemotherapy. However, the majority of advanced NSCLC patients receiving...

Cite
Tarhoni I, Wakefield CJ, Kollipara R, et al. Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition. J Immunol Methods. 2021;490:112956doi: 10.1016/j.jim.2021.112956.
Tarhoni, I., Wakefield, C. J., Kollipara, R., Fidler, M. J., Batus, M., Bonomi, P., & Borgia, J. A. (2021). Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition. Journal of immunological methods, 490112956. https://doi.org/10.1016/j.jim.2021.112956
Tarhoni, Imad, et al. "Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition." Journal of immunological methods vol. 490 (2021): 112956. doi: https://doi.org/10.1016/j.jim.2021.112956
Tarhoni I, Wakefield CJ, Kollipara R, Fidler MJ, Batus M, Bonomi P, Borgia JA. Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition. J Immunol Methods. 2021 Mar;490:112956. doi: 10.1016/j.jim.2021.112956. Epub 2021 Jan 09. PMID: 33434603.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 9375 entries